Ads
related to: Pfizer and Prices
Search results
Dow Jones hits record milestone as US bets on faster rate cuts
The Telegraph via Yahoo Finance· 4 days agoThe Dow Jones Industrial Average hit a record 40,000 this afternoon, seen as a major milestone for...
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
InvestorPlace· 5 days agoIt’s no secret that artificial intelligence (AI) promises to transform every industry and sector,...
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
InvestorPlace via Yahoo Finance· 7 days agoBiotechnology is an interesting place to look if you’re looking for growth and are not put off by...
These Healthcare Stocks Could Make A Great Addition To Any Passive Income Portfolio
Benzinga via Yahoo Finance· 3 days agoHealthcare stocks could make an attractive addition to your portfolio in May 2024, thanks to their...
Microsoft asks AI employees in China to relocate amid tensions between the U.S. and China
Quartz· 4 days agoMicrosoft is reportedly asking hundreds of its employees in China to consider relocating outside of...
Biotech Soars As Its Biggest Drug 'Lives To Fight Another Day'
Investor's Business Daily· 14 hours agoTranslarna has a conditional approval in Europe to treat patients with a muscle-wasting disease...
Trending tickers: Tesla, Reddit, Walmart and GSK
Yahoo Finance UK· 4 days agoHaleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer, sitting as a joint...
Damien Conover and Rebecca Springer: ‘We Are in a Healthcare Consumerization Moment Right Now’
Morningstar· 6 days agoDamien is director of healthcare research and director of equity strategy for Morningstar Research...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 20 hours agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C
Guru Focus· 6 days agoWith a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis to help investors make informed decisions. Viatris ...